Novanta receives Silver rating from EcoVadis

Recognition of commitment to sustainability

BEDFORD, Mass.–(BUSINESS WIRE)–Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that the Company has received a Silver rating from EcoVadis for its sustainability practices.


EcoVadis is an internationally recognized sustainability rating agency. Their Silver rating for Novanta places the Company in the top 25% of rated companies within Novanta’s industry sector and was based on EcoVadis’s assessment in four categories: environment, ethics, labor and human rights, and sustainable procurement.

“We are very proud of our progress in our environmental sustainability and our social responsibility initiatives, which we believe are important to all of Novanta’s stakeholders and will further strengthen our position as a trusted partner of leading and successful OEMs,” said Matthijs Glastra, Novanta Chair and Chief Executive Officer. “The Silver rating is a testament to our dedication and progress in reducing our environmental carbon footprint, improving our culture, and bettering our communities.”

Earlier this year, Novanta published its 2022 ESG Report giving further details of Novanta’s ESG programs and initiatives. To learn more about these programs and initiatives, please visit the Environmental, Social and Governance section of our website at: https://sustainability.novanta.com.

About Novanta

Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers a competitive advantage. We combine deep proprietary technology expertise and competencies in precision medicine and manufacturing, medical solutions, and robotics and automation with a proven ability to solve complex technical challenges. This enables Novanta to engineer core components and sub-systems that deliver extreme precision and performance, tailored to our customers’ demanding applications. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation and customer success. Novanta’s common shares are quoted on Nasdaq under the ticker symbol “NOVT.”

More information about Novanta is available on the Company’s website at www.novanta.com. For additional information, please contact Novanta Investor Relations at (781) 266-5137 or [email protected].

Contacts

Novanta Inc.

Investor Relations Contact:

Ray Nash

(781) 266-5137

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.